MiMedx Group, Inc.
NASDAQ: MDXG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph H. Capper
- Employees
- 837
- Headquarters
- Marietta, United States
- IPO year
- 2008
- Market cap
- $570.5M
- Website
- https://www.mimedx.com
Loading MDXG…
Loading profile data…Frequently asked questions about MDXG
What does MiMedx Group, Inc. (MDXG) do?
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential re...
Where does MDXG trade?
MiMedx Group, Inc. (MDXG) trades on the NASDAQ Capital Market.
What sector is MDXG in?
MiMedx Group, Inc. (MDXG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MiMedx Group, Inc.?
Joseph H. Capper is the chief executive officer of MiMedx Group, Inc. (MDXG).
Where is MiMedx Group, Inc. headquartered?
MiMedx Group, Inc. is headquartered in United States.
Does MDXG pay a dividend?
MiMedx Group, Inc. (MDXG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MDXG go public?
MiMedx Group, Inc. (MDXG) completed its initial public offering in 2008.